Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second Phase

Wayfinder Biosciences announced the advancement to the second phase of its research collaboration with Daiichi Sankyo through its Daiichi Sankyo Research Institute San Diego. The decision follows the successful completion of the initial research phase, which was focused on discovering novel RNA-targeting small molecules against a key neurodegeneration target.